David R. Elmaleh
Co-Founder & Senior AdvisorDr. David R. Elmaleh, Ph.D., is Co-Founder & Board Director of Quthero, Inc. He is a Co-Founder of PureTech Health plc and serves as its Senior Advisor. He is Founder of Mersana, MolecularInsights. Dr. Elmaleh was Scientific Founder of AZTherapies, Inc. and served as its Treasurer and Secretary until September 2021. He served as Chief Scientific Officer at AZTherapies, Inc. since October 2020 until September 2021. He served as Chief Executive Officer at AZTherapies, Inc. until 2020. He serves as the President of Xebra Pharmaceuticals. He serves as a Consultant and Scientific Board Advisor to several publicly traded biotechnology companies. He is the Founder of FluoroPharma Medical, Inc. and served as its Chief Scientific Advisor. He served as Consultant of FluoroPharma Medical, Inc. since April 2012. He has founded several biotechnology companies, including BioStream, SRD Pharmaceuticals, US BioSystems, Oncologic (merged with Procyon BioPharma) and ATP Therapeutics. Dr. Elmaleh served as Chairman of AZTherapies, Inc. He served as the Chairman and Director of FluoroPharma Medical, Inc. until June 12, 2012 and also served as its Member of Scientific Advisory Board. He serves as a Director of Contrast Media Chemistry at the Massachusetts General Hospital. He serves as a Director of MitoVec, Inc. Dr. Elmaleh was a Scientific Founder of Molecular Insight Pharmaceuticals, Inc and was its Director. He served as Director of PureTech Health plc. He is an Associate Professor at Harvard Medical School and a Reviewer for the National Institute of Health (NIH). He has co-authored or authored over 120 publications and has 40 registered patents in a range of disciplines, including imaging, pharmaceuticals and nuclear treatment. He is the recipient of numerous NIH and DOE awards. Dr. Elmaleh holds a B.S. in Physics and Chemistry and an M.S. and Ph.D. in Chemistry from the Hebrew University of Jerusalem.
Positions
- Company NamePureTech Health plcStock CodePRTCYPositionCo-Founder & Senior Advisor
